Skip to main content
رجوع
MASI logo

Masimo Corporation

جودة البيانات: 100%
ذروة شراء
MASI
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 178.69
▲ KWD 0.25 (0.14%)
القيمة السوقية: 9.60B
نطاق اليوم
KWD 177.84 KWD 178.80
نطاق 52 أسبوعًا
KWD 125.94 KWD 178.87
حجم التداول
1,587,309
متوسط 50 يوم / 200 يوم
KWD 155.89 / KWD 150.88
الإغلاق السابق
KWD 178.44

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -63.4 0.3
P/B 13.3 2.9
ROE % -17.1 3.7
Net Margin % -9.9 3.8
Rev Growth 5Y % 5.4 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 187.500 +4.9%
Low: KWD 180.000 High: KWD 200.000
مكرر الربحية المستقبلي
32.5
ربحية السهم المستقبلية
KWD 5.498
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.5 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 7.430
KWD 7.372 – KWD 7.485
2 B 1
FY2029 KWD 7.431
KWD 7.373 – KWD 7.486
1.9 B 1
FY2028 KWD 6.659
KWD 6.368 – KWD 7.179
1.7 B 6

النقاط الرئيسية

Revenue grew 5.36% annually over 5 years — modest growth
Generating 197.80M in free cash flow
PEG of 0.89 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 32.46%
Capital efficient — spends only 1.27% of revenue on capex
ROIC of 18.32% — excellent capital efficiency

النمو

Revenue Growth (5Y)
5.36%
Revenue (1Y)-27.10%
Earnings (1Y)N/A
FCF Growth (3Y)455.93%

الجودة

Return on Equity
-17.09%
ROIC18.32%
Net Margin-9.92%
Op. Margin20.49%

الأمان

Debt / Equity
0.78
Current Ratio2.49
Interest Coverage9.42

التقييم

P/E Ratio
-63.35
P/B Ratio13.31
EV/EBITDA31.99
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -27.10% Revenue Growth (3Y) -13.66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 5.36% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.53B Net Income (TTM) -151.50M
ROE -17.09% ROA -8.92%
Gross Margin 61.90% Operating Margin 20.49%
Net Margin -9.92% Free Cash Flow (TTM) 197.80M
ROIC 18.32% FCF Growth (3Y) 455.93%
Safety
Debt / Equity 0.78 Current Ratio 2.49
Interest Coverage 9.42 Dividend Yield 0.00%
Valuation
P/E Ratio -63.35 P/B Ratio 13.31
P/S Ratio 6.29 PEG Ratio 0.89
EV/EBITDA 31.99 Dividend Yield 0.00%
Market Cap 9.60B Enterprise Value 10.01B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.53B 2.09B 2.05B 2.04B 1.24B
Net Income -151.50M -304.90M 81.50M 143.50M 229.60M
EPS (Diluted) -2.80 -5.72 1.51 2.60 3.98
Gross Profit 945.20M 1.00B 1.00B 1.06B 808.40M
Operating Income 312.80M -266.70M 136.50M 210.00M 275.80M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.70B 2.63B 3.04B 3.21B 1.89B
Total Liabilities 977.70M 1.57B 1.68B 1.87B 336.80M
Shareholders' Equity 721.20M 1.05B 1.36B 1.34B 1.55B
Total Debt 559.30M 846.10M 970.00M 1.03B 32.70M
Cash & Equivalents 152.30M 177.60M 163.00M 202.90M 745.30M
Current Assets 926.00M 1.23B 1.23B 1.31B 1.24B
Current Liabilities 371.60M 617.70M 563.80M 630.00M 267.70M